Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ALD-R491 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/12/2021 1 0
Interferon beta Potential treatment - theoretical effect Used to treat other disease Antiviral May/12/2021 3 1
Interferon alfa Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/12/2021 6 1
rlcv-miR-rL1-28-3p Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021 1 0
aly-miR396a-5p Potential treatment - pre-clinical evidence Natural product Antiviral May/10/2021 1 0
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Zofin Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021 1 0
NSC Ex/Mv Potential treatment - pre-clinical evidence Experimental Antiviral Dec/18/2020 1 0
Interferon lambda-1 Potential treatment - pre-clinical evidence Natural product Antiviral Sep/15/2020 2 0
Excel (.xslx) CSV (.csv)